Optic nerve hypoplasia is a developmental anomaly which probably originates as the consequence of defective differentiation of the retinal ganglion cell layer (Duke-Elder, 1963) . Although it was once thought to be a rare anomaly, since the reports of Walton and Robb (1970) and Edwards and Layden (1970) , optic nerve hypoplasia has been recognised with increasing frequency. In 1972 we reported 10 cases seen over 18 months (Billson, 1972; Billson and Hopkins, 1972) , and since that time we have seen a further 57 cases.
Very little is known about the causative factors responsible for this developmental defect. The great majority of cases are sporadic, although a few familial cases have been documented (Missiroli, 1947; Kytila and Miettingen, 1961; and Hackenbruch et al., 1975) . Optic nerve hypoplasia has been reported as a consequence of maternal quinine ingestion (McKinna, 1966) and in association with maternal diabetes mellitus (Petersen and Walton, 1977) . In cattle optic nerve hypoplasia has been associated with bovine-mucosal disease virus (Bistner et al., 1973) . The common feature of the 7 patients reported in this paper is that all the mothers were epileptic and took anticonvulsants during pregnancy. The possibility that anticonvulsants may be an aetiological factor in some cases of optic nerve hypoplasia is discussed in the light of what is known about the teratogenicity of anticonvulsants. (Billson, 1975 McKinna (1966) reported 6 cases of optic nerve hypoplasia in which there was a history of maternal ingestioff of large quantities of quinine as an abortifacient early in the first trimester of pregnancy. The hypoplasia was bilateral and resulted in severe visual impairment in all of the patients. However, in 2 of the cases the ingestion of quinine did not take place until late in the first trimester of pregnancy, when the development of the optic nerves would have been already accomplished. Furthermore, the retinal vessels in the affected children were described as being narrow in calibre. In other reports of optic nerve hypoplasia the retinal vessels have been thought to be normal (Walton and Robb, 1970; Edwards and Layden, 1970; Billson, 1972; Petersen and Walton, 1977) . The atypical features of this report are significant. Whether quinine ingestion early in pregnancy may be a direct causative factor of optic nerve hypoplasia remains undetermined in our minds. There was no history of maternal quinine ingestion in any of the 67 cases we studied. Petersen and Walton (1977) described 17 children, born of severely diabetic mothers, who had segmental optic nerve hypoplasia. This type of optic nerve hypoplasia resulted in altitudinal or sector visual field defects, but did not impair central visual acuity. Only 3 of the cases were unilateral, but most of the bilateral cases did not show symmetrical involvement as judged by the visual fields. All of the mothers were insulin-dependent diabetics. None of the parents had any evidence of hypoplasia of the optic nerve, but 9 of the patients belonged to families with at least 1 other sibling similarly affected. We have seen 2 patients of diabetic mothers with this type of segmental optic nerve hypoplasia.
The possibility that anticonvulsants might be responsible for some congenital abnormalities was first suggested by Meadow (1968) , who noted an apparent increased incidence of cleft palate, cleft lip, and congenital heart disease in children born of mothers taking anticonvulsants during pregnancy. A subsequent retrospective study (Speidel and Meadow, 1972) documented an increased risk of congenital malformations and perinatal mortality in children of mothers with epilepsy. The commonest anomalies associated with epileptic mothers were cleft palate, cleft lip, microcephaly, and congenital heart disease. Although the authors concluded that the malformations were the result of multiple maternal factors, they did suggest that anticonvulsant drugs might have a teratogenic action. The data from over 50 000 pregnancies established that the malformation rates of children exposed to phenytoin during early gestation were greater than those of children of non-epileptic mothers or children of epileptic mothers not routinely taking phenytoin (Monson et al., 1973) .
Phenytoin has been shown to have a teratogenic effect in experimental animals (Gibson and Becker, 1968) . Furthermore, Mirkin (1971) has demonstrated the transplacental passage of phenytoin. Concentrations of the drug in the newborn babies' circulation were similar to those in the mothers'. It has been postulated that phenytoin may exert its teratogenic effect by its interference with folic acid metabolism. It has been shown by Pritchard et al. (1971) that maternal folate deficiency is commoner and more severe in patients taking phenytoin. However, they did not report that maternal folate deficiency was correlated with an increased incidence of fetal malformations.
So far there have been no reports of optic nerve anomalies in association with maternal anticonvulsant therapy. However, it is interesting to note that in case 3 described by McKinna (1966) the mother not only took a large dose of quinine but was also taking '4 or 5 grains of nembutal' daily throughout the pregnancy. A coloboma of the retina but not involving the optic nerve was reported in a child with multiple congenital defects born of a mother taking phenytoin, phenobarbitone, and primidone (Dabee et al., 1975 ).
The 7 patients described in this report were all born of mothers taking anticonvulsants during pregnancy. Although some of the mothers took more than one anticonvulsant, phenytoin was common to all the mothers. It has been proposed that seizure activity by itself may be teratogenic. In this regard it is noteworthy that 2 of the mothers in our study were seizure-free during pregnancy. It is also important to note that in 4 of our patients (1, 2, 3, and 5) there were systemic anomalies which have been associated with maternal anticonvulsant therapy. Additional collateral evidence that anticonvulsant therapy played a role in the development of the malformations in these patients is found in the observation that 2 of them had siblings who had systemic anomalies (cleft palate and ventricular septal defect) which have been associated with maternal anticonvulsant ingestion.
All of the mothers of the patients reported in this communication took phenytoin during pregnancy. In the light of what is known about the incidence of other congenital anomalies associated with maternal phenytoin ingestion this would appear to be a significant aetiological factor in the optic nerve hypoplasia of these children.
We conclude, therefore, that phenytoin appears to have well-established teratogenic properties in man, and optic nerve hypoplasia may be one of the foetal malformations associated with maternal ingestion of phenytoin. nerve hypoplasia. 
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